Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 771
Last updated 2014-01-31
Summary
The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.
Conditions
- Symptomatic Atherothrombosis
Sponsors & Collaborators
-
Beziers Hospital
collaborator OTHER -
University Hospital, Montpellier
collaborator OTHER -
Ministry of Health, France
collaborator OTHER_GOV -
Swiss National Science Foundation
collaborator OTHER -
Pierre Fontana
lead OTHER
Principal Investigators
-
Pierre Fontana, MD PhD · University Hospitals Geneva, Switzerland
-
Jean-Luc Reny, MD PhD · Beziers Hospital, France
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
Countries
- France
More Related Trials
-
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
NCT00243178 ·Status: TERMINATED ·Phase: PHASE3
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
NCT01322711 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Monitoring Response to Antiplatelet Therapy
NCT00327041 ·Status: UNKNOWN
-
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
NCT03174990 ·Status: COMPLETED
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
NCT00822536 ·Status: COMPLETED ·Phase: PHASE4
-
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
NCT00249873 ·Status: COMPLETED ·Phase: PHASE3
-
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
NCT03023020 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
NCT00249795 ·Status: COMPLETED ·Phase: PHASE3
-
Resistance on Antithrombotic Drugs in Ischemic Heart Disease
NCT00742430 ·Status: COMPLETED
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome
NCT05577988 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
NCT04271280 ·Status: COMPLETED
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
ACCEL-LOADING-ACS Study
NCT01354808 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT05125276 ·Status: UNKNOWN ·Phase: PHASE4
-
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
NCT03317002 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
NCT01212302 ·Status: COMPLETED ·Phase: NA
-
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505 ·Status: COMPLETED ·Phase: PHASE2